SCHEMBL9739129

SCHEMBL9739129

CCOC(OCC)c1nc(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)n(C(C)C)n1

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 2/20 0.35
AGTR2 P50052 1/20 0.35
CNR2 P34972 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9738526 0.94 AGTR1 (0.36) AGTR1AGTR2
SCHEMBL9739338 0.90 AGTR1 (0.33) AGTR1AGTR2CNR2
SCHEMBL9738817 0.88 CNR2 (0.34) AGTR1AGTR2CNR2
SCHEMBL9739279 0.86 AGTR1 (0.43) AGTR1AGTR2
SCHEMBL9738254 0.85 AGTR1 (0.36) AGTR1
SCHEMBL9738171 0.85 AGTR1 (0.49) AGTR1AGTR2
SCHEMBL9739015 0.85 AGTR1 (0.36) AGTR1AGTR2CNR2
SCHEMBL9737759 0.84 TRPV1 (0.33) AGTR1AGTR2
SCHEMBL9738783 0.83 SLC33A1 (0.35) AGTR1AGTR2
SCHEMBL9552979 0.82 AGTR1 (0.39) AGTR1AGTR2CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992005161-A1 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-04-02 WO claimed
WO-1992005161-A1 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-04-02 WO disclosed